InfuSystem Holdings, Inc. (INFU)

Market Cap	188.11M
Revenue (ttm)	141.05M
Net Income (ttm)	5.52M
Shares Out	20.34M
EPS (ttm)	0.26
PE Ratio	35.66
Forward PE	27.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,053
Open	9.58
Previous Close	9.63
Day's Range	9.23 - 9.65
52-Week Range	4.61 - 11.04
Beta	1.70
Analysts	Strong Buy
Price Target	14.50 (+56.76%)
Earnings Date	Nov 4, 2025

About INFU

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 514
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: INFU
• Website: https://www.infusystem.com

Financial Performance

In 2024, InfuSystem Holdings's revenue was $134.86 million, an increase of 7.22% compared to the previous year's $125.79 million. Earnings were $2.35 million, an increase of 168.92%.

Analyst Summary

According to 2 analysts, the average rating for INFU stock is "Strong Buy." The 12-month stock price target is $14.5, which is an increase of 56.76% from the latest price.

Price Target

$14.5

(56.76% upside)

Analyst Consensus: Strong Buy